PHARMACIE CLASSEN: what changed
What changed
PHARMACIE CLASSEN
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Net result for the year
€31,584
2024 · €62,145-€30,561
Equity
€486,266
2024 · €454,682+€31,584
Cash
€197,465
2024 · €188,446+€9,019
Balance sheet total
€984,256
2024 · €985,260-€1,004
Largest movements
Assets
- Receivables within one year -€16,853
down €16,853 (-12.5%), from €134,355 to €117,501
of which Trade receivables: -€11,723
Equity and liabilities
- Reserves +€31,500
up €31,500 (+7.2%), from €435,650 to €467,150
of which Distributable reserves: +€31,500
- Trade debts -€16,495
down €16,495 (-17.7%), from €93,145 to €76,650
- Other debts -€15,544
down €15,544 (-4.2%), from €367,243 to €351,700
Income statement
- Staff costs +€27,648
up €27,648 (+13.1%), from €210,388 to €238,036
- Depreciation +€14,927
up €14,927 (+43.6%), from €34,215 to €49,142
- Gross operating margin -€13,913
down €13,913 (-3.6%), from €384,654 to €370,741
- Taxes -€13,347
down €13,347 (-44.5%), from €29,963 to €16,616
- Financial charges -€5,763
down €5,763 (-18.1%), from €31,925 to €26,162
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€62,145
Gross operating margin
-€13,913
Staff costs
-€27,648
Depreciation
-€14,927
Write-downs
+€265
Other operating charges
+€5,407
Financial income
+€1,145
Financial charges
+€5,763
Taxes
+€13,347
Result 2025
€31,584
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€62,927
Investment
-€53,907
Financing
€0
Cash 2024
€188,446
From operations (derived)
+€62,927
Net result for the year
+€31,584
Depreciation
+€49,142
Stocks and contracts
-€1,323
Receivables within one year
+€16,853
Deferred charges and accrued income
-€742
Trade debts
-€16,495
Tax, wage and social debts
+€1,544
Other debts
-€15,544
Accrued charges and deferred income
-€2,093
Investment (derived)
-€53,907
Investment in fixed assets (net)
-€53,907
Cash 2025
€197,465
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €985,260 | €984,256 | -€1,004 | -0.1% |
| Fixed assets | 21/28 | €530,345 | €535,110 | +€4,765 | +0.9% |
| Intangible fixed assets | 21 | €0 | €0 | = | |
| Tangible fixed assets | 22/27 | €530,257 | €535,022 | +€4,765 | +0.9% |
| Land and buildings | 22 | €488,926 | €500,683 | +€11,757 | +2.4% |
| Furniture and vehicles | 24 | €41,331 | €34,340 | -€6,991 | -16.9% |
| Leasing and similar rights | 25 | €0 | €0 | = | |
| Financial fixed assets | 28 | €88 | €88 | = | 0.0% |
| Current assets | 29/58 | €454,915 | €449,146 | -€5,769 | -1.3% |
| Stocks and contracts in progress | 3 | €120,505 | €121,827 | +€1,323 | +1.1% |
| Stocks | 30/36 | €120,505 | €121,827 | +€1,323 | +1.1% |
| Amounts receivable within one year | 40/41 | €134,355 | €117,501 | -€16,853 | -12.5% |
| Trade receivables | 40 | €125,809 | €114,086 | -€11,723 | -9.3% |
| Other amounts receivable | 41 | €8,546 | €3,415 | -€5,131 | -60.0% |
| Cash at bank and in hand | 54/58 | €188,446 | €197,465 | +€9,019 | +4.8% |
| Deferred charges and accrued income | 490/1 | €11,610 | €12,352 | +€742 | +6.4% |
| Total equity and liabilities | 10/49 | €985,260 | €984,256 | -€1,004 | -0.1% |
| Equity | 10/15 | €454,682 | €486,266 | +€31,584 | +6.9% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €435,650 | €467,150 | +€31,500 | +7.2% |
| Tax-exempt reserves | 132 | €43,750 | €43,750 | = | 0.0% |
| Distributable reserves | 133 | €391,900 | €423,400 | +€31,500 | +8.0% |
| Profit (loss) carried forward | 14 | €432 | €516 | +€84 | +19.4% |
| Amounts payable | 17/49 | €530,578 | €497,990 | -€32,588 | -6.1% |
| Amounts payable within one year | 42/48 | €508,385 | €477,890 | -€30,495 | -6.0% |
| Trade debts | 44 | €93,145 | €76,650 | -€16,495 | -17.7% |
| Suppliers | 440/4 | €93,145 | €76,650 | -€16,495 | -17.7% |
| Taxes, remuneration and social security | 45 | €47,996 | €49,540 | +€1,544 | +3.2% |
| Taxes | 450/3 | €14,452 | €10,995 | -€3,457 | -23.9% |
| Remuneration and social security | 454/9 | €33,545 | €38,545 | +€5,001 | +14.9% |
| Other amounts payable | 47/48 | €367,243 | €351,700 | -€15,544 | -4.2% |
| Accrued charges and deferred income | 492/3 | €22,193 | €20,100 | -€2,093 | -9.4% |
| Remuneration, social security and pensions | 62 | €210,388 | €238,036 | +€27,648 | +13.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €34,215 | €49,142 | +€14,927 | +43.6% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €381 | €116 | -€265 | -69.6% |
| Other operating charges | 640/8 | €17,923 | €12,517 | -€5,407 | -30.2% |
| Gross operating margin | 9900 | €384,654 | €370,741 | -€13,913 | -3.6% |
| Operating profit (loss) | 9901 | €121,747 | €70,930 | -€50,817 | -41.7% |
| Financial income | 75/76B | €2,286 | €3,431 | +€1,145 | +50.1% |
| Recurring financial income | 75 | €2,286 | €3,431 | +€1,145 | +50.1% |
| Financial charges | 65/66B | €31,925 | €26,162 | -€5,763 | -18.1% |
| Recurring financial charges | 65 | €31,925 | €26,162 | -€5,763 | -18.1% |
| Profit (loss) for the period before taxes | 9903 | €92,108 | €48,200 | -€43,909 | -47.7% |
| Income taxes | 67/77 | €29,963 | €16,616 | -€13,347 | -44.5% |
| Profit (loss) for the period | 9904 | €62,145 | €31,584 | -€30,561 | -49.2% |
| Profit (loss) for the period to be appropriated | 9905 | €62,145 | €31,584 | -€30,561 | -49.2% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 5 November 2026 via checked.be.